Health knowledge made personal
Join this community!
› Share page:
Search posts:

Nasal Flu Vaccine OK to Age 2

Posted Aug 26 2008 4:08pm

The news broke this morning, with Reuters publishing a brief article within minutes of the coffee break. At the quarterly meeting of the Advisory Committee on Immunization Practices (ACIP) , the first order of business was discussing nasal flu vaccine.

The best explanation I have found so far is the Post’s HealthDay article , but the fact is, we may have to wait for the ACIP Minutes before we really know the exact reasons why. Having said that, it seems that a price reduction to $18 (it used to be over $70) and some good safety studies down to the age of 2, not to mention the obvious absence of a needle, has put MedImmune in the position of a significant profit potential. The news was overshadowed by parent company’s Astra-Zeneca losing a key patent today. Keep your eyes on the stock.

See what happens when you do the right thing?

Post a comment
Write a comment: